The Princess Margaret Cancer Foundation Opens the Market
TORONTO, May 30, 2023 /CNW/ - Miyo Yamashita, President and Chief Executive Officer, The Princess Margaret Cancer Foundation, and her team joined John McKenzie, Chief Executive Officer, TMX Group, to celebrate the 16th annual Ride to Conquer Cancer and open the market.
The Princess Margaret Cancer Foundation is Canada's largest and leading cancer charity, dedicated to raising funds for Princess Margaret Cancer Centre, one of the world's top five cancer research centres known for its game-changing scientific achievements and exceptional patient treatment and care. Through philanthropy, events, our world-leading home lottery program, and commercialization initiatives, we make possible the critical funding required to accelerate cancer research, education, and clinical care -- benefitting patients at Princess Margaret Cancer Centre, throughout Canada and the world. www.thepmcf.ca
ARTHEx Biotech S.L., a clinical-stage biotechnology company focused on developing innovative medicines through the modulation of microRNAs, today announced an oral presentation at the upcoming Oligonucleotide & Peptide Therapeutics (TIDES) Conference...
With every successive year, the lines between medical devices and consumer electronics become increasingly blurred ? medtech companies seek to expand their reach beyond patients, and consumer electronics companies have targeted medical applications...
The 31st Canadian Cancer Society (CCS) Daffodil Ball, which took place this evening at Windsor Station in Montreal, raised $1,474,785 to fund innovative research projects and essential support programs for people living with cancer. The largest...
The report titled "Clinical Trials Matching Software Market by Functionality (Analytics & Reporting, Compliance Tracking, Data Management), Deployment (Cloud & Web Based, On-Premise), End-Use - Global Forecast 2024-2030" is now available on...
South Korea's biotechnology company Hyundai Bioscience (CEO Oh Sang-gi, www.hyundaibioscience.com) announced on April 15 that it would carry out global clinical tests aimed at treating all serotypes of Dengue virus infection....
